ArticleFrontiers in public health2025
Impact of an analytical treatment interruption on partners and family members of trial participants in Durban, South Africa: a qualitative study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perceptions of young people living with HIV and caregivers in Botswana on analytical treatment interruption studies: a qualitative approach.HIV research & clinical practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Background: HIV cure-related research often include analytical treatment interruptions (ATIs), which are monitored pauses in antiretroviral therapy (ART) to determine whether interventions can stimulate viral control without ART. While ATIs have been conducted in high-income countries, scale-up in low-income HIV high-burden countries in sub-Saharan Africa raise unique ethical, social, and practical challenges. HIV cure-related trials focus on participants without considering the experiences of partners and family members. Here, we explore the perspectives of partners and family members, including their emotional, relational, and mental health, during an ATI-inclusive HIV cure trial conducted in Durban, South Africa. Methods: We conducted a qualitative socio-behavioral study to explore the experiences of close contacts of ATI trial participants. Between November 2022 and June 2024, we interviewed partners and family members referred by trial participants. Interviews explored understanding of the trial, emotional and relational impacts, and concerns about ATIs. The interviews were conducted in English and/or Results: Ten participants comprised five male partners (two living with HIV, three without) and five female family members (two mothers, two sisters, one cousin). Most had limited knowledge of HIV cure research but expressed hope for its advancements alongside concerns about ART discontinuation and viral rebound. Partners without HIV valued pre-exposure prophylaxis (PrEP) but reported inconsistent use, while partners with HIV feared re-infection during viral rebound. Mothers expressed concerns about ATIs, while sisters sought clearer information. Participants recommended improved communication, partner protections and psychosocial support, while acknowledging the trial's scientific importance. Conclusion: ATI-inclusive HIV cure trials affect participants and their close social networks comprised of family members and intimate partners. Ethical trials are responsible for ensuring the safety of participants and other impacted groups. Family and partners were a critical source of support for trial participants, but have been underutilized in ATI-inclusive trials. Leveraging this existing support network in future ATI trials may improve safety while facilitating recruitment, willingness to discontinue ART during ATIs, prevent early ATI discontinuation, support adherence to frequent visits and sampling requirements, improving overall trial success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.